|
Search
Collections
Benchmarks
Upload document
Organization
Hangzhou Cheetah Cell Therapeutics
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 clinical trial
Clinical trial
NKG2D CAR-NK Cell Therapy for Patients With Platinum-Resistant Recurrent Ovarian Cancer
Status: Recruiting
, Estimated PCD: 2024-04-01
